// App-Quantinova.ai

3409 : Cluster Analysis Followed by Network Meta-Analysis to Compare Efficacy and Safety of Dabigatran, Rivaroxaban and Apixaban After Elective Total Knee and Hip Replacement Surgery

Researchers

Presenter

  • Svetlana Marx

Principal Investigators

  • Shabnam Zolfaghari

  • Christel Weiss

  • Martin Wehling

  • Astrid Schulze

  • Ola E Dahl

Medical Centers

  • Clinical Pharmacology, Medical Faculty Mannheim, Mannheim, Germany

  • Biometry and Statistics, Faculty of Medicine Mannheim, Mannheim, Germany,

  • Orthopedic Center, Medical Faculty Mannheim, Mannheim, Germany

  • Innlandet Hospital Trust, Elverum Central Hospital, Elverum, Norway

  • Clinical Pharmacology, Medical Faculty Mannheim, Mannheim, Germany

Locations

  • Germany

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Transketolase Like 1

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • Pradax

  • apixaban

  • Heparin

Outcome

  • N/A

Study Design

  • active comparator

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved